Status:
NOT_YET_RECRUITING
RES-SAFE (Resorption, Safety, and Efficacy of Absorbable Collagen Membrane)
Lead Sponsor:
Hyundai Bioland Co., Ltd.
Conditions:
Guided Bone Regeneration
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The clinical study aims to assess the long-term safety and efficacy of the interventional medical device. The clinical study will enrol up to 50 patients aged 18 years and older, who meet specific inc...
Eligibility Criteria
Inclusion
- Inclusion Criteria (among others):
- Patients over 18 years old (both sex) with full legal capacity who understand the treatment and sign the informed consent and who are medically healthy, except treated condition.
- Exclusion Criteria (among others):
- Patients with dental diseases or conditions (except treated condition);
- Patients with unsatisfactory oral hygiene;
- Patients with alcohol, substance abuse, smoking habits, known allergy to collagen;
- Patients with severe or chronic diseases or with systemic inflammation and all patients classified as unhealthy;
- Pregnant or breast feeding women.
Exclusion
Key Trial Info
Start Date :
December 16 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06570265
Start Date
December 16 2024
End Date
June 30 2026
Last Update
August 26 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.